Xenetic Biosciences (XBIO) Operating Margin (2011 - 2026)
Xenetic Biosciences (XBIO) operating margin from Nov 30, 2011 to Mar 31, 2026. The current Xenetic Biosciences (XBIO) operating margin is -61.73%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Xenetic Biosciences (XBIO)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -94.97% | -43.47% |
| 2024 | -168.00% | -5.59% |
| 2023 | -177.95% | -54.72% |
| 2022 | -392.98% | -20.72% |
| 2021 | -495.69% | -84.35% |
| 2020 | -3168.18% | -95.08% |
| 2019 | -64450.00% | +136923.95% |
| 2017 | -47.04% | -97.02% |
| 2016 | -1581.00% | +83.62% |
| 2013 | -861.00% | N/A |
| 2013 | -861.00% | +1130.00% |
| 2013 | -70.00% | -96.80% |
| 2012 | -2186.21% | N/A |
| 2012 | -2186.21% | +1904.02% |
| 2012 | -109.09% | N/A |
Comparison Xenetic Biosciences (XBIO) operating margin with competitors
Xenetic Biosciences (XBIO) operating margin is -61.73%.